Lobbying

Vytalize Health's latest lobbying report covers Q2 2026, at $200K. The four quarters Q3 2025–Q2 2026 total $750K. Its first report covers Q2 2025; the issues it reports most are Health Issues and Medicare/Medicaid.

Vytalize Health

Latest quarter
$200K
Q2 2026 · 3 reports
Last 12 months
$750K
Last 4 quarters
vs last quarter
−55.6%
Q2 2026 against the quarter before
First report
Q2 2025
The first quarter a report named it

Lobbying by quarter

Vytalize Health lobbying by quarter
Vytalize Health lobbying by quarter
QuarterAmountReports
Q2 2025$40K1
Q3 2025$40K1
Q4 2025$60K1
Q1 2026$450K3
Q2 2026$200K3

Policy issues the reports name

  • Health issues7 reports
  • Medicare and Medicaid5 reports
  • Trade5 reports

A report that names several issues counts once for each.

Who was lobbied

  • Centers For Medicare and Medicaid Services (CMS)7 reports
  • HOUSE OF REPRESENTATIVES7 reports
  • SENATE7 reports
  • Health & Human Services, Dept of (HHS)2 reports
  • White House Office2 reports

Firms it paid

Firm
In-houseVytalize Health$480K2 quarters
Ankura Advocacy$260K5 quarters
Mason Street Consulting$50K2 quarters

Former officials lobbying for it

Former position
SUSAN S ZOOKLegislative Assistant, Senator Mike Crapo; Legislative Assistant, Representative Charlie Dent; Legislative Correspondent/Staff Assistant, Representative Tim MurphyQ2 2026

Lobbying reports

Filed by
07/20for Q2Ankura Advocacy$60K
07/20for Q2In-house$110K
07/07for Q2Mason Street Consulting$30K
04/20for Q1Ankura Advocacy$60K
04/13for Q1In-house$370K
04/02for Q1Mason Street Consulting$20K
03/06for Q1In-houseUnder $5,000
02/17for Q1Mason Street ConsultingUnder $5,000
01/20for Q4 2025Ankura Advocacy$60K
25/10/20for Q3 2025Ankura Advocacy$40K
25/07/21for Q2 2025Ankura Advocacy$40K
25/07/01for Q2 2025Ankura AdvocacyUnder $5,000